Prognostic importance of temporal changes in resting heart rate in heart failure patients: an analysis of the CHARM program

scientific article published on 2 November 2014

Prognostic importance of temporal changes in resting heart rate in heart failure patients: an analysis of the CHARM program is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1093/EURHEARTJ/EHU401
P698PubMed publication ID25368202
P5875ResearchGate publication ID267814200

P50authorSalim YusufQ2214381
Christopher B. GrangerQ62050240
Karl SwedbergQ65769660
Brian ClaggettQ90483213
Marc A PfefferQ114321706
Hicham SkaliQ37838150
Davide CastagnoQ51816537
Pardeep S. JhundQ52145742
John McMurrayQ56633150
P2093author name stringScott D Solomon
Ali Vazir
P2860cites workIvabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled studyQ28291971
Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programmeQ34246882
Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trialQ34246891
Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trialQ34246898
Mode of death in heart failure: findings from the ATLAS trialQ35580685
Secular trends in heart rate in young adults, 1949 to 2004: analyses of cross sectional studiesQ35771528
Elevated heart rate: a major risk factor for cardiovascular diseaseQ36035810
Resting heart rate in cardiovascular diseaseQ36919145
Is heart rate important for patients with heart failure in atrial fibrillation?Q38222202
Predictors of mortality and morbidity in patients with chronic heart failureQ39361079
Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trialQ42923271
Resting heart rate pattern during follow-up and mortality in hypertensive patientsQ43206150
Effects on outcomes of heart rate reduction by ivabradine in patients with congestive heart failure: is there an influence of beta-blocker dose?: findings from the SHIFT (Systolic Heart failure treatment with the I(f) inhibitor ivabradine Trial) stuQ43749481
Temporal changes in resting heart rate and deaths from ischemic heart diseaseQ43920198
Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved TrialQ44588075
Influence of heart rate, blood pressure, and beta-blocker dose on outcome and the differences in outcome between carvedilol and metoprolol tartrate in patients with chronic heart failure: results from the COMET trialQ46616032
Neurochemical evidence of cardiac sympathetic activation and increased central nervous system norepinephrine turnover in severe congestive heart failure.Q48164763
Association of Heart Rate and Outcomes in a Broad Spectrum of Patients With Chronic Heart FailureQ57396205
P433issue11
P304page(s)669-675
P577publication date2014-11-02
P1433published inEuropean Heart JournalQ2286839
P1476titlePrognostic importance of temporal changes in resting heart rate in heart failure patients: an analysis of the CHARM program
P478volume36

Reverse relations

cites work (P2860)
Q47182647Association between adult height, myocardial infarction, heart failure, stroke and death: a Korean nationwide population-based study
Q47647624Association of Resting Heart Rate and Temporal Changes in Heart Rate With Outcomes in Participants of the Atherosclerosis Risk in Communities Study.
Q92740551Association of patient-reported outcomes and heart rate trends in heart failure: a report from the Chiron project
Q64091025Association of resting heart rate and its change with incident cardiovascular events in the middle-aged and older Chinese
Q88723395Beta blockers and chronic heart failure patients: prognostic impact of a dose targeted beta blocker therapy vs. heart rate targeted strategy
Q90203537Effect of Once-Weekly Exenatide in Patients With Type 2 Diabetes Mellitus With and Without Heart Failure and Heart Failure-Related Outcomes: Insights From the EXSCEL Trial
Q47120245Effects of the community-based Wellspring Cancer Exercise Program on functional and psychosocial outcomes in cancer survivors
Q92462108Heart rate and blood pressure monitoring in heart failure
Q48132218Heart rate and outcome in heart failure with reduced ejection fraction: Differences between atrial fibrillation and sinus rhythm-A CIBIS II analysis.
Q89547585Inter- and intraindividual variability in daily resting heart rate and its associations with age, sex, sleep, BMI, and time of year: Retrospective, longitudinal cohort study of 92,457 adults
Q47794681Prognostic Importance of Temporal Changes in Resting Heart Rate in Heart Failure and Preserved Ejection Fraction: From the TOPCAT Study
Q90095011Prognostic value of discharge heart rate in acute heart failure patients: More relevant in atrial fibrillation?
Q92065869Relationship between heart rate and outcomes in patients in sinus rhythm or atrial fibrillation with heart failure and reduced ejection fraction
Q41899817Relationships among achieved heart rate, β-blocker dose and long-term outcomes in patients with heart failure with atrial fibrillation
Q57296974Resting Heart Rate and Chronotropic Response to Exercise: Prognostic Implications in Heart Failure Across Left Ventricular Ejection Fraction Spectrum
Q37643822Resting Heart Rate and Long-term Outcomes Among the African American Population: Insights From the Jackson Heart Study
Q89451975Temporal Changes in Resting Heart Rate, Left Ventricular Dysfunction, Heart Failure and Cardiovascular Disease: CARDIA Study
Q90299460The impact of heart rate on patients diagnosed with heart failure with mid-range ejection fraction
Q85404538[Chronic heart failure : current guideline recommendations and innovations]
Q85512879[Update on therapy of chronic heart failure. Innovations and studies from last year]